Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.
Breast cancers (BCs) of the luminal B subtype are estrogen receptor-positive (ER+), highly proliferative, resistant to standard therapies and have a poor prognosis. To better understand this subtype we compared DNA copy number aberrations (CNAs), DNA promoter methylation, gene expression profiles, a...
Main Authors: | Stéphanie Cornen, Arnaud Guille, José Adélaïde, Lynda Addou-Klouche, Pascal Finetti, Marie-Rose Saade, Marwa Manai, Nadine Carbuccia, Ismahane Bekhouche, Anne Letessier, Stéphane Raynaud, Emmanuelle Charafe-Jauffret, Jocelyne Jacquemier, Salvatore Spicuglia, Hugues de The, Patrice Viens, François Bertucci, Daniel Birnbaum, Max Chaffanet |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3886975?pdf=render |
Similar Items
-
Integrated Genomic Analysis of Breast Cancers
by: Chaffanet Max, et al.
Published: (2012-12-01) -
Genome profiling of <it>ERBB2</it>-amplified breast cancers
by: Ayed Farhat, et al.
Published: (2010-10-01) -
A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases
by: Marguerite Tyran, et al.
Published: (2019-05-01) -
<i>ZNF703</i> mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines
by: Sandra Udu-Ituma, et al.
Published: (2023-07-01) -
Nectin-4 is a new histological and serological tumor associated marker for breast cancer
by: Sauvan Richard, et al.
Published: (2007-05-01)